We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Substack by Magnus Ofstad. In this article, we will ...

We know that hypertrophic cardiomyopathy and stage heart failure is the most common related mortality ... exacerbate current health care inequities or inequalities based on this data. The next slide ...

Camzyos, which addresses hypertrophic cardiomyopathy, is already gaining traction with strong patient retention rates and could see sales reach between $2 billion and $4 billion by 2029.

Neurologists, neurology residents and fellows, medical students, social workers, masters in administration, physician assistants, nurse practitioners, nurses and pharmacists. Additionally, Neurology ...

The needle is usually in place for only a few seconds. Once enough cells or fluid have been collected, the needle is carefully removed. The sample is placed on a slide or in a container and sent to a ...

Capricor Therapeutics has completed its US marketing application for deramiocel, a cell therapy the US biotech hopes will become the first approved treatment for cardiomyopathy associated with ...

Join your program director colleagues before ACC.25 for a unique opportunity for professional development and networking. The Training Program Directors and Graduate Medical Educators (PDGME) ...

For instance, repeated cycles of anthracycline (ANT) chemotherapy (e.g., daunorubicin/DAU/ and doxorubicin) may induce the development of irreversible cardiomyopathy and chronic heart failure. Hence, ...